114 related articles for article (PubMed ID: 30667388)
1. [Clinical outcomes and hospital costs of hepatic encephalopathy: an analysis of "real life" data from Marche Region.].
Sciattella P; Mennini FS; Marcellusi A; Toraldo B; Koch M
Recenti Prog Med; 2018 Dec; 109(12):585-594. PubMed ID: 30667388
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of diverticular disease: An observational analysis based on real world data from an Italian region.
Mennini FS; Sciattella P; Marcellusi A; Toraldo B; Koch M
Dig Liver Dis; 2017 Sep; 49(9):1003-1008. PubMed ID: 28663067
[TBL] [Abstract][Full Text] [Related]
3. [Burden of diverticular disease: an observational analysis based on Italian real-world data.].
Mennini FS; Sciattella P; Marcellusi A; Toraldo B; Koch M
Recenti Prog Med; 2018 Jan; 109(1):15-24. PubMed ID: 29451517
[TBL] [Abstract][Full Text] [Related]
4. Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients.
Wang AJ; Peng AP; Li BM; Gan N; Pei L; Zheng XL; Hong JB; Xiao HY; Zhong JW; Zhu X
World J Gastroenterol; 2017 Sep; 23(34):6321-6329. PubMed ID: 28974899
[TBL] [Abstract][Full Text] [Related]
5. Burden of compensated and decompensated cirrhosis: real world data from an Italian population-based cohort study.
Cammarota S; Citarella A; Bernardi FF; Claar E; Fogliasecca M; Manzo V; Rosato V; Toraldo B; Trama U; Valente A; Conti V
Eur Rev Med Pharmacol Sci; 2021 Jul; 25(13):4490-4498. PubMed ID: 34286491
[TBL] [Abstract][Full Text] [Related]
6. Burden of Disease of Human Papillomavirus (HPV): Hospitalizations in the Marche and Veneto Regions. An observational study.
Mennini FS; Fabiano G; Marcellusi A; Sciattella P; Saia M; Cocchio S; Baldo V
Clin Drug Investig; 2018 Feb; 38(2):173-180. PubMed ID: 29081028
[TBL] [Abstract][Full Text] [Related]
7. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.
Patidar KR; Thacker LR; Wade JB; Sterling RK; Sanyal AJ; Siddiqui MS; Matherly SC; Stravitz RT; Puri P; Luketic VA; Fuchs M; White MB; Noble NA; Unser AB; Gilles H; Heuman DM; Bajaj JS
Am J Gastroenterol; 2014 Nov; 109(11):1757-63. PubMed ID: 25178701
[TBL] [Abstract][Full Text] [Related]
8. Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials.
Saab S; Suraweera D; Au J; Saab EG; Alper TS; Tong MJ
Liver Int; 2016 Jul; 36(7):986-93. PubMed ID: 26561214
[TBL] [Abstract][Full Text] [Related]
9. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
[TBL] [Abstract][Full Text] [Related]
10. The Health Care Burden of Hepatic Encephalopathy.
Elsaid MI; John T; Li Y; Pentakota SR; Rustgi VK
Clin Liver Dis; 2020 May; 24(2):263-275. PubMed ID: 32245532
[TBL] [Abstract][Full Text] [Related]
11. Health burden and economic impact of measles-related hospitalizations in Italy in 2002-2003.
Filia A; Brenna A; Panà A; Cavallaro GM; Massari M; Ciofi degli Atti ML
BMC Public Health; 2007 Jul; 7():169. PubMed ID: 17650298
[TBL] [Abstract][Full Text] [Related]
12. In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009.
Stepanova M; Mishra A; Venkatesan C; Younossi ZM
Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1034-41.e1. PubMed ID: 22642955
[TBL] [Abstract][Full Text] [Related]
13. Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs.
Roggeri DP; Roggeri A; Rossi E; Cinconze E; Gasbarrini A; Monici Preti P; De Rosa M
Hepat Med; 2015; 7():37-42. PubMed ID: 26203290
[TBL] [Abstract][Full Text] [Related]
14. Population characteristics, healthcare pathways and outcomes of patients with cirrhosis hospitalized with overt hepatic encephalopathy in France: A study of the French Hospital-Discharge Database.
Thabut D; Roux J; Sultanik P; Tamberou C; Prost PL; Hagège H
Clin Res Hepatol Gastroenterol; 2024 Mar; 48(3):102274. PubMed ID: 38154597
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomics of hepatic encephalopathy.
Neff G
Pharmacotherapy; 2010 May; 30(5 Pt 2):28S-32S. PubMed ID: 20412038
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance and economic burden of hepatic encephalopathy in liver cirrhosis in German hospitals based on G-DRG data].
Gundling F; Rathmayer M; Koller L; Wilke M; Kircheis G; Wedemeyer H; Labenz J; Albert J; Schepp W; Lerch MM;
Z Gastroenterol; 2020 Apr; 58(4):323-331. PubMed ID: 31863425
[TBL] [Abstract][Full Text] [Related]
17. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
[TBL] [Abstract][Full Text] [Related]
18. The burden of hepatic encephalopathy in Latin America.
Dávalos Moscol M; Bustios Sanchez C
Ann Hepatol; 2011 Jun; 10 Suppl 2():S31-5. PubMed ID: 22228878
[TBL] [Abstract][Full Text] [Related]
19. Probiotics for patients with hepatic encephalopathy.
McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
[TBL] [Abstract][Full Text] [Related]
20. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
